Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.

[1]  A. Skanes,et al.  How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia , 2011, Circulation. Arrhythmia and electrophysiology.

[2]  András Varró,et al.  Cardiac ventricular repolarization reserve: a principle for understanding drug‐related proarrhythmic risk , 2011, British journal of pharmacology.

[3]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.

[4]  C. January,et al.  Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes. , 2010, American journal of physiology. Heart and circulatory physiology.

[5]  Robert Passier,et al.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[6]  R. Shah.  Drug‐induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives , 2010, British journal of pharmacology.

[7]  S. Hohnloser,et al.  Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction. , 2009, Heart rhythm.

[8]  Ard Teisman,et al.  Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? , 2009, Journal of pharmacological and toxicological methods.

[9]  R. Kass,et al.  The Cardiac IKs Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3* , 2009, Journal of Biological Chemistry.

[10]  N. Guérard,et al.  Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart. , 2008, Journal of pharmacological and toxicological methods.

[11]  A. Camm,et al.  New antiarrhythmic drugs for atrial fibrillation: Focus on dronedarone and vernakalant , 2008, Journal of Interventional Cardiac Electrophysiology.

[12]  H. R. Lu,et al.  Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines , 2008, British journal of pharmacology.

[13]  Tianen Yang,et al.  Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism , 2008, Journal of Pharmacology and Experimental Therapeutics.

[14]  G. Abbott,et al.  Impact of ancillary subunits on ventricular repolarization. , 2007, Journal of electrocardiology.

[15]  S. Bryant,et al.  Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization. , 2007, Journal of pharmacological and toxicological methods.

[16]  Bba,et al.  Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene , 2007, Circulation.

[17]  K. Letsas,et al.  QT interval prolongation and torsade de pointes associated with indapamide. , 2006, International journal of cardiology.

[18]  J. Nerbonne,et al.  Molecular physiology of cardiac repolarization. , 2005, Physiological reviews.

[19]  László Virág,et al.  Restricting Excessive Cardiac Action Potential and QT Prolongation: A Vital Role for IKs in Human Ventricular Muscle , 2005, Circulation.

[20]  P. C. Viswanathan,et al.  Genetics of acquired long QT syndrome. , 2005, The Journal of clinical investigation.

[21]  Robert Passier,et al.  Increased Cardiomyocyte Differentiation from Human Embryonic Stem Cells in Serum‐Free Cultures , 2005, Stem cells.

[22]  M. Carlson.  Azimilide dihydrochloride , 2005, Expert review of cardiovascular therapy.

[23]  E. Stanley,et al.  The hESC line Envy expresses high levels of GFP in all differentiated progeny , 2005, Nature Methods.

[24]  Marc A. Vos,et al.  Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for &bgr;-Adrenergic Receptor Stimulation , 2003, Circulation.

[25]  B. Fermini,et al.  The impact of drug-induced QT interval prolongation on drug discovery and development , 2003, Nature Reviews Drug Discovery.

[26]  Stefan Kääb,et al.  Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol. , 2003, European heart journal.

[27]  C. Antzelevitch,et al.  HMR 1556, A Potent and Selective Blocker of Slowly Activating Delayed Rectifier Potassium Current , 2003, Journal of cardiovascular pharmacology.

[28]  J. Papp,et al.  Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve , 2002, British journal of pharmacology.

[29]  J. Papp,et al.  Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QTc and action potential duration , 2001, British journal of pharmacology.

[30]  László Virág,et al.  The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization , 2000, The Journal of physiology.

[31]  S. Priori,et al.  Low penetrance in the long-QT syndrome: clinical impact. , 1999, Circulation.

[32]  D. Roden.  Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes , 1998, Pacing and clinical electrophysiology : PACE.

[33]  S Nattel,et al.  Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.

[34]  R. Kass,et al.  Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  L. Klein.  QT-interval prolongation produced by probucol. , 1981, Archives of internal medicine.

[36]  J. Weinreb.  HOW TO PERFORM AND INTERPRET PROSTATE MRI , 2013 .

[37]  벤자민 프라이어,et al.  Differentiation of human embryonic stem cells , 2011 .

[38]  Hua-rong Lu,et al.  Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation. , 2008, Journal of pharmacological and toxicological methods.